Present the technological capabilities, R&D activities, and investment opportunities. Israel is a recognized leader of innovative developments in the world of high tech and has become a leading provider of innovative solutions in the field of life science seeking to meet today’s healthcare challenges. Israel spends 8% of its GDP on healthcare. It boasts a very high level of healthcare and an extensive infrastructure of quality resources that range from local community clinics to world-renowned trauma centers. The country has a high ratio of MDs to population (3.5 per 1,000) and the highest concentration of PhDs and engineers per capita in the world. With over 1,400 innovative Life Science companies operating in Israel such as Teva, Dexcel, Taro, BTG, Pluristem, Compugen, Neuroderm, and CellCure to name a few, Israel boast some $30 Billion in sales of blockbuster drugs invented locally including: Humira by AbbVie, Enbrel by Amgen, Copaxon by Teva and many more.
Join our presentation to learn more about why you should invest in Israel.
Session ID: 21855